Skip to main content

Table 2 Association between HLA alleles and KSHV DNA detection in saliva and peripheral blood among children in the Uganda Sickle Cell Anemia KSHV Study, 2001-2002

From: HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the uganda sickle cell anemia KSHV Study

Allele

# KSHV DNA positive/#KSHV DNA negative

OR (95% CI)

P-value

# KSHV DNA positive/#KSHV DNA negative

OR (95% CI)

P-value

Saliva

A priori-motivated analyses

  

Peripheral blood

  

HLA-A*30

      

   Absent

20/121

1

 

26/130

1

 

   At least 1 *3001

5/29

1.1 (0.5-4.3)

0.5

3/23

0.6 (0.2-2.2)

0.8

   At least *3002

9/24

1.8 (0.8-4.1)

0.2

7/34

1.1 (0.5-2.7)

0.9

HLA-A*68

      

   Absent

30/139

1

 

31/153

1

 

   At least1*6801

0/6

0.0

0.6

1/5

1.0 (0.1-9.2)

1.0

   At least1*6802

4/29

0.5 (0.1-1.8)

0.3

4/29

0.7 (0.2-2.3)

0.6

HLA-DRB1*04

      

   Absent

32/173

1

 

34/187

1

 

   At least 1*0405

1/3

1.8 (0.1-5.2)

0.5

2/2

5.5 (0.7-40.3)

0.1

Explorative analyses

      

   HLA-B*08

      

   Absent

31/160

1

 

29/176

1

 

   At least 1*0801

3/14

1.1 (0.3-4.1)

0.9

7/11

3.9 (1.4-10.8)

0.01

HLA-B*44

      

   Absent

30/165

1

 

33/176

1

 

   At least 1*4403

1/6

1.1 (0.1- 9.9)

0.9

2/6

1.9 (0.3-9.1)

0.2

   At least 1*4415

3/3

5.5 (1.1-28.6)

0.02

1/5

1.1 (0.1-9.2)

0.9

  1. KSHV: Kaposi-sarcoma-associated herpesvirus; OR: odds ratio; 95% CI: 95% confidence interval; HLA-A, -B, -DRB1: Human leucocyte antigen -A, -B, -DRB1